Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an "iffy" question!

Sónia C. Correia, Cristina Carvalho, Susana Cardoso, Renato X. Santos, Ana I. Plácido, Emanuel Candeias, Ana I. Duarte, Paula I. Moreira (Corresponding Author)

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Brain structural and functional integrity exquisitely relies on a regular supply of oxygen. In order to circumvent the potential deleterious consequences of deficient oxygen availability, brain triggers endogenous adaptive and pro-survival mechanisms - a phenomenon known as brain hypoxic tolerance. The highly conserved hypoxia-inducible family (HIF) of transcription factors is the “headquarter” of the homeostatic response of the brain to hypoxia. HIF acts as a cellular oxygen sensor and regulates the expression of proteins involved in a broad range of biological processes, including neurogenesis, angiogenesis, erythropoiesis, and glucose metabolism, and thus, enables brain cells to survive in low-oxygen conditions. Hypoxia, as well as hypoxia-reoxygenation, is intimately implicated in the clinical and pathological course of several neurodegenerative diseases. Thus, two major questions can arise: Is HIF signaling and brain response to hypoxia compromised in neurodegenerative diseases? If so, are HIF stabilizers a possible therapeutic strategy to halt or prevent the progression of neurodegenerative diseases? This review highlights the current knowledge pertaining the role of HIF on brain response to hypoxia and its close association with the development of Alzheimer’s, and Parkinson’s disease and amyotrophic lateral sclerosis. Finally, the potential therapeutic effects of HIF stabilizers (deferoxamine, clioquinol, M30, HLA20, DHB, FG0041, and VK-28) against the symptomatic and neuropathological features of the abovementioned neurodegenerative diseases will be discussed.
Original languageEnglish
Pages (from-to)6809-6822
Number of pages14
JournalCurrent Pharmaceutical Design
Volume19
Issue number38
DOIs
Publication statusPublished - 2013

Fingerprint

Neurodegenerative Diseases
Brain
Oxygen
Clioquinol
Hypoxia
Biological Phenomena
Brain Hypoxia
Deferoxamine
Erythropoiesis
Neurogenesis
Amyotrophic Lateral Sclerosis
Therapeutic Uses
Parkinson Disease
Alzheimer Disease
Transcription Factors
Glucose

Keywords

  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis
  • hypoxia
  • hypoxia-inducible factor
  • neurodegeneration
  • neuroprotection
  • Parkinson’s disease

Cite this

Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases : not an "iffy" question! / Correia, Sónia C.; Carvalho, Cristina; Cardoso, Susana; Santos, Renato X.; Plácido, Ana I.; Candeias, Emanuel; Duarte, Ana I.; Moreira, Paula I. (Corresponding Author).

In: Current Pharmaceutical Design, Vol. 19, No. 38, 2013, p. 6809-6822.

Research output: Contribution to journalArticle

Correia, SC, Carvalho, C, Cardoso, S, Santos, RX, Plácido, AI, Candeias, E, Duarte, AI & Moreira, PI 2013, 'Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an "iffy" question!', Current Pharmaceutical Design, vol. 19, no. 38, pp. 6809-6822. https://doi.org/10.2174/1381612811319380013
Correia, Sónia C. ; Carvalho, Cristina ; Cardoso, Susana ; Santos, Renato X. ; Plácido, Ana I. ; Candeias, Emanuel ; Duarte, Ana I. ; Moreira, Paula I. / Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases : not an "iffy" question!. In: Current Pharmaceutical Design. 2013 ; Vol. 19, No. 38. pp. 6809-6822.
@article{c43ca9a6acc143e98614821506144a06,
title = "Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an {"}iffy{"} question!",
abstract = "Brain structural and functional integrity exquisitely relies on a regular supply of oxygen. In order to circumvent the potential deleterious consequences of deficient oxygen availability, brain triggers endogenous adaptive and pro-survival mechanisms - a phenomenon known as brain hypoxic tolerance. The highly conserved hypoxia-inducible family (HIF) of transcription factors is the “headquarter” of the homeostatic response of the brain to hypoxia. HIF acts as a cellular oxygen sensor and regulates the expression of proteins involved in a broad range of biological processes, including neurogenesis, angiogenesis, erythropoiesis, and glucose metabolism, and thus, enables brain cells to survive in low-oxygen conditions. Hypoxia, as well as hypoxia-reoxygenation, is intimately implicated in the clinical and pathological course of several neurodegenerative diseases. Thus, two major questions can arise: Is HIF signaling and brain response to hypoxia compromised in neurodegenerative diseases? If so, are HIF stabilizers a possible therapeutic strategy to halt or prevent the progression of neurodegenerative diseases? This review highlights the current knowledge pertaining the role of HIF on brain response to hypoxia and its close association with the development of Alzheimer’s, and Parkinson’s disease and amyotrophic lateral sclerosis. Finally, the potential therapeutic effects of HIF stabilizers (deferoxamine, clioquinol, M30, HLA20, DHB, FG0041, and VK-28) against the symptomatic and neuropathological features of the abovementioned neurodegenerative diseases will be discussed.",
keywords = "Alzheimer’s disease, Amyotrophic lateral sclerosis, hypoxia, hypoxia-inducible factor, neurodegeneration, neuroprotection, Parkinson’s disease",
author = "Correia, {S{\'o}nia C.} and Cristina Carvalho and Susana Cardoso and Santos, {Renato X.} and Pl{\'a}cido, {Ana I.} and Emanuel Candeias and Duarte, {Ana I.} and Moreira, {Paula I.}",
year = "2013",
doi = "10.2174/1381612811319380013",
language = "English",
volume = "19",
pages = "6809--6822",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "38",

}

TY - JOUR

T1 - Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases

T2 - not an "iffy" question!

AU - Correia, Sónia C.

AU - Carvalho, Cristina

AU - Cardoso, Susana

AU - Santos, Renato X.

AU - Plácido, Ana I.

AU - Candeias, Emanuel

AU - Duarte, Ana I.

AU - Moreira, Paula I.

PY - 2013

Y1 - 2013

N2 - Brain structural and functional integrity exquisitely relies on a regular supply of oxygen. In order to circumvent the potential deleterious consequences of deficient oxygen availability, brain triggers endogenous adaptive and pro-survival mechanisms - a phenomenon known as brain hypoxic tolerance. The highly conserved hypoxia-inducible family (HIF) of transcription factors is the “headquarter” of the homeostatic response of the brain to hypoxia. HIF acts as a cellular oxygen sensor and regulates the expression of proteins involved in a broad range of biological processes, including neurogenesis, angiogenesis, erythropoiesis, and glucose metabolism, and thus, enables brain cells to survive in low-oxygen conditions. Hypoxia, as well as hypoxia-reoxygenation, is intimately implicated in the clinical and pathological course of several neurodegenerative diseases. Thus, two major questions can arise: Is HIF signaling and brain response to hypoxia compromised in neurodegenerative diseases? If so, are HIF stabilizers a possible therapeutic strategy to halt or prevent the progression of neurodegenerative diseases? This review highlights the current knowledge pertaining the role of HIF on brain response to hypoxia and its close association with the development of Alzheimer’s, and Parkinson’s disease and amyotrophic lateral sclerosis. Finally, the potential therapeutic effects of HIF stabilizers (deferoxamine, clioquinol, M30, HLA20, DHB, FG0041, and VK-28) against the symptomatic and neuropathological features of the abovementioned neurodegenerative diseases will be discussed.

AB - Brain structural and functional integrity exquisitely relies on a regular supply of oxygen. In order to circumvent the potential deleterious consequences of deficient oxygen availability, brain triggers endogenous adaptive and pro-survival mechanisms - a phenomenon known as brain hypoxic tolerance. The highly conserved hypoxia-inducible family (HIF) of transcription factors is the “headquarter” of the homeostatic response of the brain to hypoxia. HIF acts as a cellular oxygen sensor and regulates the expression of proteins involved in a broad range of biological processes, including neurogenesis, angiogenesis, erythropoiesis, and glucose metabolism, and thus, enables brain cells to survive in low-oxygen conditions. Hypoxia, as well as hypoxia-reoxygenation, is intimately implicated in the clinical and pathological course of several neurodegenerative diseases. Thus, two major questions can arise: Is HIF signaling and brain response to hypoxia compromised in neurodegenerative diseases? If so, are HIF stabilizers a possible therapeutic strategy to halt or prevent the progression of neurodegenerative diseases? This review highlights the current knowledge pertaining the role of HIF on brain response to hypoxia and its close association with the development of Alzheimer’s, and Parkinson’s disease and amyotrophic lateral sclerosis. Finally, the potential therapeutic effects of HIF stabilizers (deferoxamine, clioquinol, M30, HLA20, DHB, FG0041, and VK-28) against the symptomatic and neuropathological features of the abovementioned neurodegenerative diseases will be discussed.

KW - Alzheimer’s disease

KW - Amyotrophic lateral sclerosis

KW - hypoxia

KW - hypoxia-inducible factor

KW - neurodegeneration

KW - neuroprotection

KW - Parkinson’s disease

UR - http://europepmc.org/abstract/med/23530518

U2 - 10.2174/1381612811319380013

DO - 10.2174/1381612811319380013

M3 - Article

C2 - 23530518

VL - 19

SP - 6809

EP - 6822

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 38

ER -